Epygen Labs Bio World Congress 2012
Bio World Congress 2012
April 1, 2012
News Thrombolytic Drug Epygen Labs
A World Class Thrombolytic Drug At An Affordable Cost For The Masses
September 1, 2013

Epygen Opens Biotechnology Incubation Facility In India And Breaks Ground For Therapeutic Protein Plant

Epygen is pleased to announce opening of a state of art, Biotech incubation facility at Navi Mumbai, India. This consists of a full- fledged Bioprocessing Pilot facility, a Microbiology Laboratory and a Protein analysis division, suitable for evaluation and incubation of licensed Technologies to produce Therapeutic proteins and Enzymes of interest.

A large scale Biotech facility at Patalganga (Maharashtra, India) is under construction to support manufacturing and development activities of the group.

Epygen is a Biotechnology company focused on designing, development and manufacturing of Enzyme Proteins for Industrial and Therapeutic applications. Taking the protein lab to the process floor, Epygen produces proteins with highest standards of purity and functionality. It has Research and Manufacturing facilities based in Dubai, Colorado and Mumbai.